title: Macrophage activation syndrome in the course of monogenic autoinflammatory disorders.
abstract: An overwhelming activation of cytotoxic T cells and well-differentiated macrophages leading to systemic overload of inflammatory mediators characterizes the so-called macrophage activation syndrome (MAS); this potentially life-threatening clinical entity may derive from several genetic defects involved in granule-mediated cytotoxicity but has been largely observed in patients with juvenile idiopathic arthritis, many rheumatologic diseases, infections, and malignancies. The occurrence of MAS in the natural history or as the revealing clue of monogenic autoinflammatory disorders (AIDs), rare conditions caused by disrupted innate immunity pathways with overblown release of proinflammatory cytokines, has been only reported in few isolated patients with cryopyrin-associated periodic syndrome, mevalonate kinase deficiency, familial Mediterranean fever, and tumor necrosis factor receptor-associated periodic syndrome since 2001. All these patients displayed various clinical, laboratory, and histopathologic features of MAS and have often required intensive care support. Only one patient has died due to MAS. Defective cytotoxic cell function was documented in a minority of patients. Corticosteroids were the first-line treatment, but anakinra was clinically effective in three refractory cases. Even if MAS and AIDs share multiple clinical features as well as heterogeneous pathogenetic scenes and a potential response to anti-interleukin-1 targeted therapies, MAS requires a prompt specific recognition in the course of AIDs due to its profound severity and high mortality rate.
authors.affiliation: Institute of Pediatrics, Università Cattolica Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli, Rome, Italy.
authors.forename: Donato
authors.initials: D
authors.lastname: Rigante
authors.forename: Giacomo
authors.initials: G
authors.lastname: Emmi
authors.forename: Michele
authors.initials: M
authors.lastname: Fastiggi
authors.forename: Elena
authors.initials: E
authors.lastname: Silvestri
authors.forename: Luca
authors.initials: L
authors.lastname: Cantarini
mesh_terms: D001171:Arthritis, Juvenile / Q000150:complications* / Q000276:immunology; D056660:Hereditary Autoinflammatory Diseases / Q000150:complications* / Q000276:immunology; D006801:Humans; D055501:Macrophage Activation Syndrome / Q000150:complications* / Q000276:immunology
references.citation: Arthritis Rheum. 2004 Jun;50(6):1935-8
references.pmid: 15188370
references.citation: Arthritis Rheum. 2011 Feb;63(2):545-55
references.pmid: 21280009
references.citation: Nat Genet. 2014 Oct;46(10):1140-6
references.pmid: 25217959
references.citation: Semin Immunol. 2013 Dec 15;25(6):439-48
references.pmid: 24275602
references.citation: J Crohns Colitis. 2010 Sep;4(3):341-4
references.pmid: 21122524
references.citation: Rheumatology (Oxford). 2011 Feb;50(2):417-9
references.pmid: 20693540
references.citation: Pediatr Blood Cancer. 2007 Feb;48(2):124-31
references.pmid: 16937360
references.citation: Arthritis Care Res (Hoboken). 2011 May;63(5):780-3
references.pmid: 21557533
references.citation: Eur Rev Med Pharmacol Sci. 2010 Jan;14(1):1-18
references.pmid: 20184084
references.citation: Rheumatology (Oxford). 2010 Sep;49(9):1645-53
references.pmid: 20472718
references.citation: Blood. 2005 Nov 15;106(10):3483-9
references.pmid: 16020503
references.citation: Arthritis Care Res (Hoboken). 2015 Aug;67(8):1173-9
references.pmid: 25469482
references.citation: Am J Physiol Heart Circ Physiol. 2014 Apr 1;306(7):H1025-31
references.pmid: 24531812
references.citation: Pediatrics. 2011 Jul;128(1):e152-9
references.pmid: 21708801
references.citation: Arthritis Rheumatol. 2014 May;66(5):1377
references.pmid: 24782193
references.citation: Genes Immun. 2012 Jun;13(4):289-98
references.pmid: 22418018
references.citation: BMC Med. 2013 Aug 22;11:185
references.pmid: 23968282
references.citation: Med Sci Monit. 2009 Aug;15(8):RA179-87
references.pmid: 19644432
references.citation: Am J Respir Crit Care Med. 2014 Feb 1;189(3):242-4
references.pmid: 24484327
references.citation: Clin Exp Rheumatol. 2013 May-Jun;31(3 Suppl 77):99-102
references.pmid: 24064022
references.citation: Arthritis Rheumatol. 2014 Oct;66(10):2871-80
references.pmid: 25044674
references.citation: Arthritis Rheum. 2007 Feb;56(2):658-61
references.pmid: 17265501
references.citation: Eur Rev Med Pharmacol Sci. 2006 Mar-Apr;10(2):53-9
references.pmid: 16705949
references.citation: BMC Infect Dis. 2013 Jan 16;13:15
references.pmid: 23324497
references.citation: Arch Dis Child. 2001 Nov;85(5):421-6
references.pmid: 11668110
references.citation: Joint Bone Spine. 2013 Dec;80(6):653-5
references.pmid: 23751410
references.citation: Biomed Res Int. 2013;2013:485103
references.pmid: 23971037
references.citation: Nat Rev Drug Discov. 2012 Aug;11(8):633-52
references.pmid: 22850787